This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: University of Michigan. Active years: 2010-2013.
Company Filing History:
Years Active: 2010-2013
Title: Soichiro Yasuda: Innovator in Cardiovascular Treatments
Introduction: Soichiro Yasuda is a prominent inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of cardiovascular health through his innovative research and patented inventions. With a focus on treating and preventing heart disease, Yasuda's work is vital for advancing medical treatments.
Latest Patents: Yasuda holds 2 patents related to compositions and methods for treating and preventing cardiomyopathy and heart disease. His latest patents involve compositions comprising poloxamers, such as poloxamer 188 (P188), which are used for treating heart disease, particularly in subjects with muscular dystrophy. These inventions also address the treatment of cells and tissue damage caused by ischemia and cell death, specifically targeting dystrophin-deficient cells like myocytes.
Career Highlights: Yasuda is affiliated with the University of Michigan, where he conducts his research and develops his innovative solutions. His work has garnered attention for its potential to improve the quality of life for individuals suffering from heart-related conditions.
Collaborations: Yasuda collaborates with esteemed colleagues, including Joseph M Metzger and Dewayne Townsend, to further enhance the impact of his research in the medical community.
Conclusion: Soichiro Yasuda's contributions to cardiovascular treatments through his patents and research at the University of Michigan highlight his dedication to improving health outcomes. His innovative approaches are paving the way for advancements in the treatment of heart disease.